drugset

drugset / Trial / NCT01099124

Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)

NCT01099124 ↗

Completed 25 enrolled Tianjin Medical University Cancer Institute and Hospital

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate safety and tolerance of M2ES with TC regimen in advanced NSCLC.

Timeline

Start: 2009-12
Primary completion: 2011-07
Completion: 2011-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	M2ES	Protein / enzyme biologic	—	—

Indications